Big firms have grown risk averse, developing lots of imitations of blockbuster drugs and fewer novel ones.
Big firms have grown risk averse, developing lots of imitations of blockbuster drugs and fewer novel ones.
大公司已经不愿承担风险，它们开发了许多已被广泛接受药物的效仿品，而创新药品则更少了。